American Society of Hematology

Figure 1

$Figure 1. Flow cytometric analyses of PBMCs isolated from patients with FHL before initiation of treatment. The staining of samples and flow cytometric analyses were performed as described previously.16,17 These results are shown as a percentage of the total PBMC fraction. For normal controls, the range of the percentage of cell subtypes is shown. In the case of P59 and P1002, samples for microarray and flow cytometric analyses were taken at different times.$

Flow cytometric analyses of PBMCs isolated from patients with FHL before initiation of treatment. The staining of samples and flow cytometric analyses were performed as described previously.^16,17 These results are shown as a percentage of the total PBMC fraction. For normal controls, the range of the percentage of cell subtypes is shown. In the case of P59 and P1002, samples for microarray and flow cytometric analyses were taken at different times.

This Feature Is Available To Subscribers Only